Another year, another WHO Global TB Report - and it’s really not looking good…
Three days ago we downloaded the new WHO Annual Global Report on TB and started workjing through it. It was a pretty horrible experience. As was anticipated in last year’s annual Report, most of the estimated global numbers relating to TB during 2021 year are up: estimated incident cases (up 4.5%), estimated mortalities (up 6.6%), estimated MDR-TB cases (up 3.4%) among others. Please note here that all these percentages reflect estimations so we shouldn't be 100% confident of
Vaccine pipeline for TB
We’ve just come across this: the Treatment Action Group’s ‘Tuberculosis Vaccines – Pipeline Report 2022’. It's a terrific analysis of where we are today with new vaccine development for TB. If you're at all interested in global health and equity of provision, we really encourage you to read it (it's not too long), but we hope that TAG won’t mind our extracting some of their excellent text and adding some contextual commentary of our own to it. We’re certainly sure they won’t
Moxafrica arrives in KwaZulu Natal, South Africa
Starting next week, an exciting new initiative begins in South Africa. Once again the focus will be on in moxa and TB, but on this occasion with an interesting new twist. We have been invited by the ‘Bellhaven Harm Reduction Centre’ in the centre of Durban, to come and introduce (and train, of course) their staff to moxa. Home - Bellhaven (bellhavenharmreductioncentre.co.za) A total of five (!) issues that make this new initiative potentially really significant... We accepted
